deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03083353

Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Craving Nicotine Dependence Smoking Behaviors Smoking Cessation Smoking Reduction Smoking, Cigarette
Interventions Cue Exposure Isradipine
Updated 14 times since 2017 Last updated: May 29, 2025 Started: Jan 22, 2020 Primary completion: Jun 14, 2023 Completion: Jun 14, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Craving and Nicotine Dependence, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 14 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Jan 2020 · 16 months · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshot~Jun 2022 – ~Dec 2022 · 6 months · monthly snapshot~Dec 2022 – ~Feb 2024 · 14 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshot~Jul 2025 – present · 14 months · monthly snapshot

Change History

14 versions recorded

  1. Jul 2025 — Present [monthly]

    Completed EARLY_PHASE1

  2. Sep 2024 — Jul 2025 [monthly]

    Completed EARLY_PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  4. Feb 2024 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

    Status: Recruiting → Completed

  5. Dec 2022 — Feb 2024 [monthly]

    Recruiting EARLY_PHASE1

▶ Show 9 earlier versions

  1. Jun 2022 — Dec 2022 [monthly]

    Recruiting EARLY_PHASE1

  2. Jun 2021 — Jun 2022 [monthly]

    Recruiting EARLY_PHASE1

  3. Jan 2021 — Jun 2021 [monthly]

    Recruiting EARLY_PHASE1

  4. Mar 2020 — Jan 2021 [monthly]

    Recruiting EARLY_PHASE1

    Status: Suspended → Recruiting

  5. Jan 2020 — Mar 2020 [monthly]

    Suspended EARLY_PHASE1

  6. Sep 2018 — Jan 2020 [monthly]

    Suspended EARLY_PHASE1

    Status: Recruiting → Suspended

  7. Jun 2018 — Sep 2018 [monthly]

    Recruiting EARLY_PHASE1

  8. Jun 2017 — Jun 2018 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  9. May 2017 — Jun 2017 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute on Drug Abuse (NIDA)
  • University of Texas at Austin
Data source: University of Texas at Austin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations